Literature DB >> 3940823

Comparison of gastric inhibitory polypeptide and intraduodenal or intravenous fat on gastric acid secretion from vagally innervated and denervated canine stomach.

S J Konturek, J Konturek, M Cieszkowski, R Ebert, W Creutzfeldt.   

Abstract

Gastric inhibitory polypeptide (GIP), given to dogs in graded doses (range 0.25-2 micrograms/kg/hr) against a constant background stimulation with pentagastrin (4 micrograms/kg/hr), failed to affect the acid secretion at all doses used except the largest one (2 micrograms/kg/hr) which significantly reduced the acid secretion only from the vagally denervated portion of the stomach (Heidenhain pouch, HP) while raising plasma GIP two to three times above the levels reached with duodenal fat. GIP infused in a constant dose (1 microgram/kg/hr) significantly reduced the HP responses to lower (0.5-2 micrograms/kg/hr) but not to higher (4-16 micrograms/kg/hr) doses of pentagastrin, the kinetics of this inhibition being of competitive type. GIP was ineffective against a constant near maximal stimulation with pentagastrin (4 micrograms/kg/hr), histamine (40 micrograms/kg/hr), or liver extract meal, whereas fat (10 g), given intraduodenally or intravenously, was a powerful inhibitor of acid responses to these stimulants both from the innervated and denervated stomach. Plasma GIP reached similar levels with exogenous GIP and duodenal fat but remained unchanged with intravenous infusion of fat.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940823     DOI: 10.1007/bf01347909

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  A COMPARISON OF ESTIMATES OF MICHAELIS-MENTEN KINETIC CONSTANTS FROM VARIOUS LINEAR TRANSFORMATIONS.

Authors:  J E DOWD; D S RIGGS
Journal:  J Biol Chem       Date:  1965-02       Impact factor: 5.157

2.  Effect of pH of gastric and intestinal meals on gastric acid and plasma gastrin and secretin responses in the dog.

Authors:  S J Konturek; P L Rayford; J C Thompson
Journal:  Am J Physiol       Date:  1977-12

3.  Inhibition of histamine-, pentagastrin-, and insulin-stimulated canine gastric secretion by pure "gastric inhibitory polypeptide".

Authors:  R A Pederson; J C Brown
Journal:  Gastroenterology       Date:  1972-03       Impact factor: 22.682

4.  Analysis of inhibition of acid secretion by cholecystokinin in dogs.

Authors:  L R Johnson; M I Grossman
Journal:  Am J Physiol       Date:  1970-02

5.  Preparation of highly active enterogastrone.

Authors:  J C Brown; R A Pederson; E Jorpes; V Mutt
Journal:  Can J Physiol Pharmacol       Date:  1969-01       Impact factor: 2.273

6.  Effect of perfusion of intestinal loops with acid, fat, or dextrose on gastric secretion.

Authors:  S Konturek; M I Grossman
Journal:  Gastroenterology       Date:  1965-11       Impact factor: 22.682

7.  Effect of intravenous lipid on gastric acid secretion stimulated by intravenous amino acids.

Authors:  A A Varner; J I Isenberg; J D Elashoff; C B Lamers; V Maxwell; A A Shulkes
Journal:  Gastroenterology       Date:  1980-11       Impact factor: 22.682

8.  Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats.

Authors:  R Ebert; K Illmer; W Creutzfeldt
Journal:  Gastroenterology       Date:  1979-03       Impact factor: 22.682

9.  Intravenous fat emulsion and gastric secretion in the rat.

Authors:  P E Baume; H C Meng; D H Law
Journal:  Am J Dig Dis       Date:  1966-01

10.  Effect of gastric inhibitory polypeptide on pentagastrin-stimulated acid secretion in man.

Authors:  V Maxwell; A Shulkes; J C Brown; T E Solomon; J H Walsh; M I Grossman
Journal:  Dig Dis Sci       Date:  1980-02       Impact factor: 3.199

View more
  1 in total

1.  Effects of intravenous and intraduodenal fat on jejunal motility and on plasma cholecystokinin in man.

Authors:  C Guedon; P Ducrotte; J A Chayvialle; E Lerebours; P Denis; R Colin
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.